1. Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor.
- Author
-
Suryavanshi, Hemant, Chaudhari, Raju D., Patil, Vishakha, Majumdar, Swapan, Debnath, Sudhan, and Biswas, Goutam
- Subjects
- *
COVID-19 , *PROTEASE inhibitors , *SARS-CoV-2 , *ALKENES , *PIPERIDINE , *COMPARATIVE studies , *HYDROCARBONS , *COMPUTER-assisted molecular modeling , *MOLECULAR structure , *ACYCLIC acids , *AMINO acids , *PHARMACODYNAMICS - Abstract
Purpose: Vortioxetine an anti-depressant FDA-drug recently reported showing better in vitro efficacy against SARS-CoV-2. Methods: In this study, we have synthesized ten new derivatives having alkenes, alkynes, benzyl, aryl, and mixed carbamate at the N-terminal of vortioxetine. Then the binding energy and interactions with the crucial amino acid residues in the binding pocket of main protease (Mpro) of SARS-CoV-2, of reported and ten newly synthesized vortioxetine derivatives (total thirty-one) in comparison with remdesivir are analyzed and presented in this paper. Results: Based on the docking scores predicted by ADV and AD, most vortioxetine derivatives showed better binding efficiency towards Mpro of SARS-CoV-2 in comparison with remdesivir (an EUA approved drug against SARS-CoV-2 Mpro) and vortioxetine. Conclusion: This study shows that some vortioxetine derivatives can be developed into promising drugs for COVID-19 treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF